Tumor Necrosis Factor-alpha and Interleukin-18 Levels in Children With Gingivitis and Type 1 Diabetes Mellitus

NCT03910205 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2019-11-29

No results posted yet for this study

Summary

This study aimed to evaluate the levels of interleukin 18 and tumor necrosis factor-alpha (TNF-α) in gingival crevicular fluid (GCF) of children with type 1 diabetes mellitus and gingivitis.

Conditions

  • Periodontal Diseases

Interventions

DIAGNOSTIC_TEST

ELISA

Enzim linked immunoabsorbant assay

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Principal Investigators

  • Sultan KELES, Dr. · Dr.

Eligibility

Min Age
7 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-08
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03910205 on ClinicalTrials.gov